about
Disappearance of GFP-positive hepatocytes transplanted into the liver of syngeneic wild-type rats pretreated with retrorsine.The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity modelToll-like receptor 3 ligand polyinosinic:polycytidylic acid promotes wound healing in human and murine skin.Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes.Induction of IL-4 release and upregulated expression of protease activated receptors by GM-CSF in P815 cells.Successful transplantation of kidney allografts in sensitized rats after syngeneic hematopoietic stem cell transplantation and fludarabine.IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis.Involvement of IL-37 in the Pathogenesis of Proliferative Diabetic Retinopathy.Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: Roles and potential therapeutic targetsModulation of mast cell proteinase-activated receptor expression and IL-4 release by IL-12Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient miceHigh-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesisAngiogenesis mediated by toll-like receptor 4 in ischemic neural tissueInflammation in the Tumor MicroenvironmentHIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary HypertensionRELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling
P50
Q33567726-EE7F12E0-D6A9-4DA2-90FA-184C29B348E9Q33938242-1DEC3593-2C29-4A2E-9327-A07544A9B92DQ34264020-400B49F2-2871-4F2C-AE20-C9A0CE9177F5Q34328240-E95872A2-3036-4D96-8BAF-BDA516DF2C3DQ36711055-8AE2E9C2-A2FF-498D-88FE-7614E6C8D702Q37877818-26461FC1-5EA8-45A4-BC2B-F96078FA764FQ39608604-4C5984F7-CBF0-4BCB-B31F-43FED6978C54Q39817481-0A49C314-478F-4EC1-BB90-56DC1CBDC503Q50450890-5B2BABB1-E716-493B-86E7-CC53D181295AQ50552201-42855E0F-4868-4054-8905-D5AFC8CFA745Q51714731-9F572EFE-4D69-4536-A71E-A4B5197DB836Q58798664-00706997-285D-4758-996A-405B771A4C65Q80529187-D53F69AE-052E-4AB5-A648-DAC87FB4AE5CQ83402955-D9521AF4-7BE8-4CA3-A863-F77B4EDCD407Q83524736-B194FF51-7A04-4D84-963B-DD76D661B38BQ85653931-34E7FC00-F0F2-4DBA-A959-68CCC3BDCD5FQ90407143-0D426187-BD39-4F82-909A-B0B6858EF9FFQ90614662-F34CAB2F-0123-4443-BA98-44ED54C15E35Q90701104-2057C5BA-285C-4C66-9F60-4C07AF408D31
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Qing Lin
@ast
Qing Lin
@en
Qing Lin
@es
Qing Lin
@nl
type
label
Qing Lin
@ast
Qing Lin
@en
Qing Lin
@es
Qing Lin
@nl
prefLabel
Qing Lin
@ast
Qing Lin
@en
Qing Lin
@es
Qing Lin
@nl
P106
P31
P496
0000-0002-8890-800X